1. Home
  2. CIX vs ALDX Comparison

CIX vs ALDX Comparison

Compare CIX & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

HOLD

Current Price

$24.22

Market Cap

284.2M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.64

Market Cap

293.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
ALDX
Founded
1993
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.2M
293.0M
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
CIX
ALDX
Price
$24.22
$4.64
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
5.3K
890.1K
Earning Date
03-04-2026
02-27-2026
Dividend Yield
9.07%
N/A
EPS Growth
2.86
N/A
EPS
1.57
N/A
Revenue
$159,004,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$36.25
P/E Ratio
$15.47
N/A
Revenue Growth
5.52
N/A
52 Week Low
$17.89
$1.14
52 Week High
$32.30
$7.20

Technical Indicators

Market Signals
Indicator
CIX
ALDX
Relative Strength Index (RSI) 56.50 50.02
Support Level $22.57 $3.95
Resistance Level $24.62 $4.33
Average True Range (ATR) 0.47 0.29
MACD 0.11 -0.00
Stochastic Oscillator 59.81 50.18

Price Performance

Historical Comparison
CIX
ALDX

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: